PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility related traits and PON1 activity in Indian women with the syndrome

Monday, June 29, 2015

Authors:
Roshan Dadachanji, M.Sc., Nuzhat Shaikh, M.Sc., Sushma Khavale, B.Sc., Anushree Patil, M.D., Nalini Shah, M.D., Srabani Mukherjee, Ph.D.…

Read More

Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome

Thursday, February 20, 2014
A factor analysis identified multiple factors that are responsible for the abnormalities associated with PCOS. Hyperandrogenemia was a common underlying feature of the metabolic and reproductive abnormalities in women with PCOS.

Read More

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome

Thursday, November 1, 2012
In studying the association of adrenal and ovarian androgens with metabolic parameters in women with polycystic ovary syndrome, distinguishing between adrenal and ovarian hyperandrogenism is important to evaluate metabolic risk.

Read More

Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome

Thursday, May 31, 2012
In women with PCOS, hyperandrogenemia appears to diminish during reproductive life whereas insulin resistance persists. This progressive worsening of insulin resistance is primarily driven by the increase in obesity.

Read More

Translate »